Flu Vaccine Market Report

Global Flu Vaccine Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 09, 2022
  • PAGES：175
  • REPORT CODE：GMM872323
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Flu Vaccine market report explains the definition, types, applications, major countries, and major players of the Flu Vaccine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Sanofi Pasteur

    • Pfizer

    • AstraZeneca

    • Mylan

    • Johnson & Johnson

    • CSL

    • GSK

    By Type:

    • Whole Virus Vaccines

    • Split Virus Vaccines

    • Subunit Vaccines

    • Live Attenuated Virus Vaccines

    By End-User:

    • For Children (6 months to 3 years)

    • For Adults and Children over 3 years

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Flu Vaccine Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Flu Vaccine Outlook to 2028- Original Forecasts

    • 2.2 Flu Vaccine Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Flu Vaccine Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Flu Vaccine Market- Recent Developments

    • 6.1 Flu Vaccine Market News and Developments

    • 6.2 Flu Vaccine Market Deals Landscape

    7 Flu Vaccine Raw Materials and Cost Structure Analysis

    • 7.1 Flu Vaccine Key Raw Materials

    • 7.2 Flu Vaccine Price Trend of Key Raw Materials

    • 7.3 Flu Vaccine Key Suppliers of Raw Materials

    • 7.4 Flu Vaccine Market Concentration Rate of Raw Materials

    • 7.5 Flu Vaccine Cost Structure Analysis

      • 7.5.1 Flu Vaccine Raw Materials Analysis

      • 7.5.2 Flu Vaccine Labor Cost Analysis

      • 7.5.3 Flu Vaccine Manufacturing Expenses Analysis

    8 Global Flu Vaccine Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Flu Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Flu Vaccine Export by Region (Top 10 Countries) (2017-2028)

    9 Global Flu Vaccine Market Outlook by Types and Applications to 2022

    • 9.1 Global Flu Vaccine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Whole Virus Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Split Virus Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Subunit Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Live Attenuated Virus Vaccines Consumption and Growth Rate (2017-2022)

    • 9.2 Global Flu Vaccine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global For Children (6 months to 3 years) Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global For Adults and Children over 3 years Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Flu Vaccine Market Analysis and Outlook till 2022

    • 10.1 Global Flu Vaccine Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Flu Vaccine Consumption (2017-2022)

      • 10.2.2 Canada Flu Vaccine Consumption (2017-2022)

      • 10.2.3 Mexico Flu Vaccine Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Flu Vaccine Consumption (2017-2022)

      • 10.3.2 UK Flu Vaccine Consumption (2017-2022)

      • 10.3.3 Spain Flu Vaccine Consumption (2017-2022)

      • 10.3.4 Belgium Flu Vaccine Consumption (2017-2022)

      • 10.3.5 France Flu Vaccine Consumption (2017-2022)

      • 10.3.6 Italy Flu Vaccine Consumption (2017-2022)

      • 10.3.7 Denmark Flu Vaccine Consumption (2017-2022)

      • 10.3.8 Finland Flu Vaccine Consumption (2017-2022)

      • 10.3.9 Norway Flu Vaccine Consumption (2017-2022)

      • 10.3.10 Sweden Flu Vaccine Consumption (2017-2022)

      • 10.3.11 Poland Flu Vaccine Consumption (2017-2022)

      • 10.3.12 Russia Flu Vaccine Consumption (2017-2022)

      • 10.3.13 Turkey Flu Vaccine Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Flu Vaccine Consumption (2017-2022)

      • 10.4.2 Japan Flu Vaccine Consumption (2017-2022)

      • 10.4.3 India Flu Vaccine Consumption (2017-2022)

      • 10.4.4 South Korea Flu Vaccine Consumption (2017-2022)

      • 10.4.5 Pakistan Flu Vaccine Consumption (2017-2022)

      • 10.4.6 Bangladesh Flu Vaccine Consumption (2017-2022)

      • 10.4.7 Indonesia Flu Vaccine Consumption (2017-2022)

      • 10.4.8 Thailand Flu Vaccine Consumption (2017-2022)

      • 10.4.9 Singapore Flu Vaccine Consumption (2017-2022)

      • 10.4.10 Malaysia Flu Vaccine Consumption (2017-2022)

      • 10.4.11 Philippines Flu Vaccine Consumption (2017-2022)

      • 10.4.12 Vietnam Flu Vaccine Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Flu Vaccine Consumption (2017-2022)

      • 10.5.2 Colombia Flu Vaccine Consumption (2017-2022)

      • 10.5.3 Chile Flu Vaccine Consumption (2017-2022)

      • 10.5.4 Argentina Flu Vaccine Consumption (2017-2022)

      • 10.5.5 Venezuela Flu Vaccine Consumption (2017-2022)

      • 10.5.6 Peru Flu Vaccine Consumption (2017-2022)

      • 10.5.7 Puerto Rico Flu Vaccine Consumption (2017-2022)

      • 10.5.8 Ecuador Flu Vaccine Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Flu Vaccine Consumption (2017-2022)

      • 10.6.2 Kuwait Flu Vaccine Consumption (2017-2022)

      • 10.6.3 Oman Flu Vaccine Consumption (2017-2022)

      • 10.6.4 Qatar Flu Vaccine Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Flu Vaccine Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Flu Vaccine Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Flu Vaccine Consumption (2017-2022)

      • 10.7.2 South Africa Flu Vaccine Consumption (2017-2022)

      • 10.7.3 Egypt Flu Vaccine Consumption (2017-2022)

      • 10.7.4 Algeria Flu Vaccine Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Flu Vaccine Consumption (2017-2022)

      • 10.8.2 New Zealand Flu Vaccine Consumption (2017-2022)

    11 Global Flu Vaccine Competitive Analysis

    • 11.1 Sanofi Pasteur

      • 11.1.1 Sanofi Pasteur Company Details

      • 11.1.2 Sanofi Pasteur Flu Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Sanofi Pasteur Flu Vaccine Main Business and Markets Served

      • 11.1.4 Sanofi Pasteur Flu Vaccine Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Pfizer

      • 11.2.1 Pfizer Company Details

      • 11.2.2 Pfizer Flu Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Pfizer Flu Vaccine Main Business and Markets Served

      • 11.2.4 Pfizer Flu Vaccine Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 AstraZeneca

      • 11.3.1 AstraZeneca Company Details

      • 11.3.2 AstraZeneca Flu Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 AstraZeneca Flu Vaccine Main Business and Markets Served

      • 11.3.4 AstraZeneca Flu Vaccine Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Mylan

      • 11.4.1 Mylan Company Details

      • 11.4.2 Mylan Flu Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Mylan Flu Vaccine Main Business and Markets Served

      • 11.4.4 Mylan Flu Vaccine Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Johnson & Johnson

      • 11.5.1 Johnson & Johnson Company Details

      • 11.5.2 Johnson & Johnson Flu Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Johnson & Johnson Flu Vaccine Main Business and Markets Served

      • 11.5.4 Johnson & Johnson Flu Vaccine Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 CSL

      • 11.6.1 CSL Company Details

      • 11.6.2 CSL Flu Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 CSL Flu Vaccine Main Business and Markets Served

      • 11.6.4 CSL Flu Vaccine Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 GSK

      • 11.7.1 GSK Company Details

      • 11.7.2 GSK Flu Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 GSK Flu Vaccine Main Business and Markets Served

      • 11.7.4 GSK Flu Vaccine Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    12 Global Flu Vaccine Market Outlook by Types and Applications to 2028

    • 12.1 Global Flu Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Whole Virus Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Split Virus Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Subunit Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Live Attenuated Virus Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Flu Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global For Children (6 months to 3 years) Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global For Adults and Children over 3 years Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Flu Vaccine Market Analysis and Outlook to 2028

    • 13.1 Global Flu Vaccine Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Flu Vaccine Consumption Forecast (2022-2028)

      • 13.2.2 Canada Flu Vaccine Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Flu Vaccine Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Flu Vaccine Consumption Forecast (2022-2028)

      • 13.3.2 UK Flu Vaccine Consumption Forecast (2022-2028)

      • 13.3.3 Spain Flu Vaccine Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Flu Vaccine Consumption Forecast (2022-2028)

      • 13.3.5 France Flu Vaccine Consumption Forecast (2022-2028)

      • 13.3.6 Italy Flu Vaccine Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Flu Vaccine Consumption Forecast (2022-2028)

      • 13.3.8 Finland Flu Vaccine Consumption Forecast (2022-2028)

      • 13.3.9 Norway Flu Vaccine Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Flu Vaccine Consumption Forecast (2022-2028)

      • 13.3.11 Poland Flu Vaccine Consumption Forecast (2022-2028)

      • 13.3.12 Russia Flu Vaccine Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Flu Vaccine Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Flu Vaccine Consumption Forecast (2022-2028)

      • 13.4.2 Japan Flu Vaccine Consumption Forecast (2022-2028)

      • 13.4.3 India Flu Vaccine Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Flu Vaccine Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Flu Vaccine Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Flu Vaccine Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Flu Vaccine Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Flu Vaccine Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Flu Vaccine Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Flu Vaccine Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Flu Vaccine Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Flu Vaccine Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Flu Vaccine Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Flu Vaccine Consumption Forecast (2022-2028)

      • 13.5.3 Chile Flu Vaccine Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Flu Vaccine Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Flu Vaccine Consumption Forecast (2022-2028)

      • 13.5.6 Peru Flu Vaccine Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Flu Vaccine Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Flu Vaccine Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Flu Vaccine Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Flu Vaccine Consumption Forecast (2022-2028)

      • 13.6.3 Oman Flu Vaccine Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Flu Vaccine Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Flu Vaccine Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Flu Vaccine Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Flu Vaccine Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Flu Vaccine Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Flu Vaccine Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Flu Vaccine Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Flu Vaccine Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Flu Vaccine Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Flu Vaccine

    • Figure of Flu Vaccine Picture

    • Table Global Flu Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Flu Vaccine Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Whole Virus Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Split Virus Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Subunit Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Live Attenuated Virus Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global For Children (6 months to 3 years) Consumption and Growth Rate (2017-2022)

    • Figure Global For Adults and Children over 3 years Consumption and Growth Rate (2017-2022)

    • Figure Global Flu Vaccine Consumption by Country (2017-2022)

    • Table North America Flu Vaccine Consumption by Country (2017-2022)

    • Figure United States Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Canada Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Mexico Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Table Europe Flu Vaccine Consumption by Country (2017-2022)

    • Figure Germany Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure UK Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Spain Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Belgium Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure France Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Italy Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Denmark Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Finland Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Norway Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Sweden Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Poland Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Russia Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Turkey Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Table APAC Flu Vaccine Consumption by Country (2017-2022)

    • Figure China Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Japan Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure India Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Korea Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Thailand Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Singapore Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Philippines Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Table South America Flu Vaccine Consumption by Country (2017-2022)

    • Figure Brazil Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Colombia Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Chile Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Argentina Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Peru Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Table GCC Flu Vaccine Consumption by Country (2017-2022)

    • Figure Bahrain Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Oman Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Qatar Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Table Africa Flu Vaccine Consumption by Country (2017-2022)

    • Figure Nigeria Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Africa Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Egypt Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Algeria Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Table Oceania Flu Vaccine Consumption by Country (2017-2022)

    • Figure Australia Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Flu Vaccine Consumption and Growth Rate (2017-2022)

    • Table Sanofi Pasteur Company Details

    • Table Sanofi Pasteur Flu Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Pasteur Flu Vaccine Main Business and Markets Served

    • Table Sanofi Pasteur Flu Vaccine Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Flu Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Flu Vaccine Main Business and Markets Served

    • Table Pfizer Flu Vaccine Product Portfolio

    • Table AstraZeneca Company Details

    • Table AstraZeneca Flu Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Flu Vaccine Main Business and Markets Served

    • Table AstraZeneca Flu Vaccine Product Portfolio

    • Table Mylan Company Details

    • Table Mylan Flu Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Flu Vaccine Main Business and Markets Served

    • Table Mylan Flu Vaccine Product Portfolio

    • Table Johnson & Johnson Company Details

    • Table Johnson & Johnson Flu Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Flu Vaccine Main Business and Markets Served

    • Table Johnson & Johnson Flu Vaccine Product Portfolio

    • Table CSL Company Details

    • Table CSL Flu Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSL Flu Vaccine Main Business and Markets Served

    • Table CSL Flu Vaccine Product Portfolio

    • Table GSK Company Details

    • Table GSK Flu Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Flu Vaccine Main Business and Markets Served

    • Table GSK Flu Vaccine Product Portfolio

    • Figure Global Whole Virus Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Split Virus Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Subunit Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Live Attenuated Virus Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global For Children (6 months to 3 years) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global For Adults and Children over 3 years Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Flu Vaccine Consumption Forecast by Country (2022-2028)

    • Table North America Flu Vaccine Consumption Forecast by Country (2022-2028)

    • Figure United States Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Flu Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Germany Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Flu Vaccine Consumption Forecast by Country (2022-2028)

    • Figure China Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Flu Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Brazil Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Flu Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Flu Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Flu Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Australia Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Flu Vaccine Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US